Vice President North America Medical Affairs
Debra (Debbie) Bensen-Kennedy has over 15 years of experience in clinical development. She joined CSL Behring in 2011 and has held increasingly broader roles including serving as the therapeutic head of coagulation, acquired bleeding, oncology, immunology, critical care, respiratory and transplant. During that time, she successfully led the Voncento®, IDELVION®, Afstyla® and HAEGARDA® programs to regulatory authorization. In her current role, Debbie is responsible for providing strategic and operational medical leadership for the US and Canada and is a key member of the regional leadership team.
Prior to joining CSL Behring, Debbie was a Senior Medical Director at Cephalon Inc., a global biopharmaceutical company, where she was responsible for all phases of clinical development in Medical Oncology and Hematology.
Debbie earned her Doctor of Medicine at Medical College of Virginia and her internal medicine training was completed at the University of Maryland. Her hematology, transfusion and medical oncology fellowship training was completed at Johns Hopkins University. She also spent several years at the Bloomberg School of Public Health, Johns Hopkins University in graduate studies for clinical investigation.